As a PI4-kinase (PI4K) inhibitor, PIK-93 was found to reduce PD-L1 expression in tumor cells and M1 macrophages and suppress tumor growth when combined with an anti-PD-L1 antibody [53]. Here, CD274 is linked to neoplasm.